Clinical Trial: Platform Study of VSV-Based Recombinant Oncolytic Viruses for the Treatment of Advanced Malignant Tumors

U.S., June 19 -- ClinicalTrials.gov registry received information related to the study (NCT07656116) titled 'Platform Study of VSV-Based Recombinant Oncolytic Viruses for the Treatment of Advanced Malignant Tumors' on Jan. 28.

Brief Summary: To evaluate the safety and tolerability of combined administration of VSV injection solutions carrying different targets via multiple routes for treating advanced malignant solid tumors.

Study Start Date: Jan. 29

Study Type: INTERVENTIONAL

Condition: Advanced Solid Tumor

Intervention: BIOLOGICAL: VSV injection

Administer twice every two weeks.

Recruitment Status: RECRUITING

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Published by HT Digital Content Services wit...